Oncotarget CREB5: A Master Regulator of Stem Cell-Like Programs in Prostate Cancer Progression In this study, through both computational and molecular characterization of PC cell lines, we determined... read more April 7, 2026
Oncotarget Predicting Colorectal Cancer Survival: How Machine Learning Combines Clinical and Biological Clues Understanding both the biological and clinical aspects of the patient is essential to uncover the... read more March 25, 2026
Oncotarget CAR-T Cell Therapy: A Revolutionary Approach to Cancer Treatment Given the small percentage of patients cured from advanced-stage disease, there is still a considerable... read more March 10, 2026
Oncotarget mRNA COVID-19 Vaccination and Cancer Risk: A Case-Based Review The carcinogenic risk associated with these technologies, which has long been known within the gene... read more February 27, 2026
Oncotarget How HPV and COVID-19 Spike Proteins May Interact to Impact Cancer Suppression Thus, the present hypothesis is that virally encoded proteins such as HPV-E6 or SARS-COV-2 Spike... read more February 9, 2026
Oncotarget Exploring Possible Links Between COVID-19 Vaccination, Infection, and Cancer These findings underscore the need for rigorous epidemiologic, longitudinal, clinical, histopathological, forensic, and mechanistic studies... read more January 26, 2026
Oncotarget Overcoming Aromatase Inhibitor Resistance in Breast Cancer: A New Therapeutic Strategy The estrogen receptor is overexpressed in and promotes 67-80% and 90% of female and male... read more January 13, 2026
Oncotarget Comprehensive Genomic Profiling in Cancer: Insights from Over 10,000 Tumors The OncoExTra® assay (formerly GEM ExTra) is a whole exome, whole transcriptome, tumor-normal genomic profiling... read more December 15, 2025
Oncotarget Repurposing Statins: Exploring Anti-Tumor Effects in Colorectal Cancer Drug repurposing has gained traction as a viable strategy to target dysregulated oncogenic pathways."Colorectal... read more December 3, 2025
Oncotarget New Antibody Removes Tregs to Boost Immune Response Against Cancer Treg play a deleterious role in the tumor microenvironment by suppressing anti-tumor effector T cells."... read more November 19, 2025